Literature DB >> 7519878

Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM.

S A Smith1, R A DiCioccio, J P Struewing, D F Easton, H H Gallion, H Albertsen, S Mazoyer, B Johansson, E Steichen-Gersdorf, M Stratton.   

Abstract

A breast-ovarian cancer susceptibility gene, BRCA1, which is responsible for disease in approximately 45% of breast cancer families and most families that contain breast and ovarian cancer, has been assigned by genetic linkage to 17q12-21. Here, we report the analysis of three marker-disease recombinants in families that contain breast and ovarian cancer, two of which strongly suggest a location for BRCA1 telomeric to D17S702, a microsatellite polymorphism, and a third which suggests a location centromeric to EDH17B, the gene encoding estradiol-17B dehydrogenase. If the interpretation of these recombinants is correct, the results localise BRCA1 to an interval of < or = 1 cM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519878     DOI: 10.1002/gcc.2870100112

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

Review 1.  Molecular genetics of familial breast-ovarian cancer.

Authors:  E J van Rensburg; B A Ponder
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

2.  Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

Authors:  E Steichen-Gersdorf; H H Gallion; D Ford; C Girodet; D F Easton; R A DiCioccio; G Evans; M A Ponder; C Pye; S Mazoyer
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

3.  Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

Authors:  J P Struewing; L C Brody; M R Erdos; R G Kase; T R Giambarresi; S A Smith; F S Collins; M A Tucker
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

4.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Authors:  S A Narod; D Ford; P Devilee; R B Barkardottir; H T Lynch; S A Smith; B A Ponder; B L Weber; J E Garber; J M Birch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 5.  The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.

Authors:  Andrew D Skol; Mark M Sasaki; Kenan Onel
Journal:  Breast Cancer Res       Date:  2016-10-03       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.